BUNGE GLOBAL SA (BG)

CH1300646267 - Common Stock

79.1  +1.18 (+1.51%)

Premarket: 79 -0.1 (-0.13%)

Fundamental Rating

6

Overall BG gets a fundamental rating of 6 out of 10. We evaluated BG against 91 industry peers in the Food Products industry. While BG has a great profitability rating, there are some minor concerns on its financial health. BG is valued quite cheap, but it does not seem to be growing. These ratings could make BG a good candidate for value investing.



7

1. Profitability

1.1 Basic Checks

BG had positive earnings in the past year.
In the past year BG had a positive cash flow from operations.
BG had positive earnings in 4 of the past 5 years.
In the past 5 years BG reported 4 times negative operating cash flow.

1.2 Ratios

BG has a better Return On Assets (8.84%) than 87.91% of its industry peers.
With an excellent Return On Equity value of 20.67%, BG belongs to the best of the industry, outperforming 90.11% of the companies in the same industry.
BG has a better Return On Invested Capital (13.58%) than 90.11% of its industry peers.
BG had an Average Return On Invested Capital over the past 3 years of 12.86%. This is above the industry average of 8.82%.
The last Return On Invested Capital (13.58%) for BG is above the 3 year average (12.86%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROIC 13.58%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%

1.3 Margins

BG's Profit Margin of 3.77% is fine compared to the rest of the industry. BG outperforms 60.44% of its industry peers.
In the last couple of years the Profit Margin of BG has grown nicely.
Looking at the Operating Margin, with a value of 5.34%, BG is in line with its industry, outperforming 59.34% of the companies in the same industry.
In the last couple of years the Operating Margin of BG has grown nicely.
With a Gross Margin value of 8.15%, BG is not doing good in the industry: 76.92% of the companies in the same industry are doing better.
BG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BG is still creating some value.
BG has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BG has more shares outstanding
BG has a worse debt/assets ratio than last year.

2.2 Solvency

BG has an Altman-Z score of 4.27. This indicates that BG is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of BG (4.27) is better than 83.52% of its industry peers.
The Debt to FCF ratio of BG is 2.23, which is a good value as it means it would take BG, 2.23 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BG (2.23) is better than 76.92% of its industry peers.
BG has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
BG has a Debt to Equity ratio (0.45) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Altman-Z 4.27
ROIC/WACC1.52
WACC8.92%

2.3 Liquidity

BG has a Current Ratio of 2.13. This indicates that BG is financially healthy and has no problem in meeting its short term obligations.
BG has a better Current ratio (2.13) than 68.13% of its industry peers.
BG has a Quick Ratio of 1.20. This is a normal value and indicates that BG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.20, BG is doing good in the industry, outperforming 70.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.2

2

3. Growth

3.1 Past

BG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.55%.
BG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 38.94% yearly.
The Revenue for BG has decreased by -11.44% in the past year. This is quite bad
The Revenue has been growing slightly by 5.41% on average over the past years.
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y38.94%
EPS Q2Q%-23.41%
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Sales Q2Q%-9.27%

3.2 Future

Based on estimates for the next years, BG will show a decrease in Earnings Per Share. The EPS will decrease by -9.97% on average per year.
The Revenue is expected to decrease by -0.76% on average over the next years.
EPS Next Y-29.39%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%
EPS Next 5YN/A
Revenue Next Year-10.9%
Revenue Next 2Y-4.64%
Revenue Next 3Y-0.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.35, which indicates a rather cheap valuation of BG.
95.60% of the companies in the same industry are more expensive than BG, based on the Price/Earnings ratio.
BG is valuated cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
BG is valuated reasonably with a Price/Forward Earnings ratio of 8.36.
Based on the Price/Forward Earnings ratio, BG is valued cheaper than 97.80% of the companies in the same industry.
BG's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.73.
Industry RankSector Rank
PE 7.35
Fwd PE 8.36

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BG indicates a rather cheap valuation: BG is cheaper than 91.21% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, BG is valued cheaply inside the industry as 91.21% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.83
EV/EBITDA 2.92

4.3 Compensation for Growth

The decent profitability rating of BG may justify a higher PE ratio.
A cheap valuation may be justified as BG's earnings are expected to decrease with -9.97% in the coming years.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%

6

5. Dividend

5.1 Amount

BG has a Yearly Dividend Yield of 3.49%.
Compared to an average industry Dividend Yield of 3.83, BG pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, BG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.49%

5.2 History

The dividend of BG has a limited annual growth rate of 4.77%.
BG has paid a dividend for at least 10 years, which is a reliable track record.
BG has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.77%
Div Incr Years4
Div Non Decr Years23

5.3 Sustainability

17.08% of the earnings are spent on dividend by BG. This is a low number and sustainable payout ratio.
DP17.08%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%

BUNGE GLOBAL SA

NYSE:BG (12/20/2024, 8:04:00 PM)

Premarket: 79 -0.1 (-0.13%)

79.1

+1.18 (+1.51%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)02-05 2025-02-05/bmo
Inst Owners89.25%
Inst Owner Change-3.8%
Ins Owners0.92%
Ins Owner Change0.11%
Market Cap10.56B
Analysts80
Price Target109.79 (38.8%)
Short Float %1.84%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield 3.49%
Dividend Growth(5Y)4.77%
DP17.08%
Div Incr Years4
Div Non Decr Years23
Ex-Date02-18 2025-02-18 (0.68)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.16%
Min EPS beat(2)16.26%
Max EPS beat(2)28.05%
EPS beat(4)3
Avg EPS beat(4)19.05%
Min EPS beat(4)-2.41%
Max EPS beat(4)34.32%
EPS beat(8)5
Avg EPS beat(8)17.17%
EPS beat(12)9
Avg EPS beat(12)38.71%
EPS beat(16)12
Avg EPS beat(16)95.75%
Revenue beat(2)0
Avg Revenue beat(2)-6.77%
Min Revenue beat(2)-9.85%
Max Revenue beat(2)-3.69%
Revenue beat(4)1
Avg Revenue beat(4)-5.93%
Min Revenue beat(4)-10.88%
Max Revenue beat(4)0.68%
Revenue beat(8)3
Avg Revenue beat(8)-4.42%
Revenue beat(12)6
Avg Revenue beat(12)1.79%
Revenue beat(16)7
Avg Revenue beat(16)0.97%
PT rev (1m)-3.43%
PT rev (3m)-6.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-0.38%
EPS NY rev (3m)-0.62%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.02%
Revenue NY rev (3m)-1.93%
Valuation
Industry RankSector Rank
PE 7.35
Fwd PE 8.36
P/S 0.18
P/FCF 4.83
P/OCF 3.19
P/B 0.97
P/tB 1.06
EV/EBITDA 2.92
EPS(TTM)10.76
EY13.6%
EPS(NY)9.46
Fwd EY11.96%
FCF(TTM)16.38
FCFY20.7%
OCF(TTM)24.78
OCFY31.33%
SpS446.06
BVpS81.29
TBVpS74.65
PEG (NY)N/A
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA 8.84%
ROE 20.67%
ROCE 17.99%
ROIC 13.58%
ROICexc 16.56%
ROICexgc 17.59%
OM 5.34%
PM (TTM) 3.77%
GM 8.15%
FCFM 3.67%
ROA(3y)7.99%
ROA(5y)4.3%
ROE(3y)21.59%
ROE(5y)12.18%
ROIC(3y)12.86%
ROIC(5y)10.32%
ROICexc(3y)15.13%
ROICexc(5y)11.93%
ROICexgc(3y)16.14%
ROICexgc(5y)12.82%
ROCE(3y)17%
ROCE(5y)14%
ROICexcg growth 3Y28.52%
ROICexcg growth 5Y24.42%
ROICexc growth 3Y29.5%
ROICexc growth 5Y26.05%
OM growth 3Y17.85%
OM growth 5Y25.08%
PM growth 3Y11.64%
PM growth 5Y49.21%
GM growth 3Y6.61%
GM growth 5Y10.47%
F-Score7
Asset Turnover2.35
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 2.23
Debt/EBITDA 1.34
Cap/Depr 248.78%
Cap/Sales 1.88%
Interest Coverage 6.27
Cash Conversion 91.08%
Profit Quality 97.46%
Current Ratio 2.13
Quick Ratio 1.2
Altman-Z 4.27
F-Score7
WACC8.92%
ROIC/WACC1.52
Cap/Depr(3y)159.64%
Cap/Depr(5y)131.69%
Cap/Sales(3y)1.13%
Cap/Sales(5y)1.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.55%
EPS 3Y19.26%
EPS 5Y38.94%
EPS Q2Q%-23.41%
EPS Next Y-29.39%
EPS Next 2Y-16.79%
EPS Next 3Y-9.97%
EPS Next 5YN/A
Revenue 1Y (TTM)-11.44%
Revenue growth 3Y12.87%
Revenue growth 5Y5.41%
Sales Q2Q%-9.27%
Revenue Next Year-10.9%
Revenue Next 2Y-4.64%
Revenue Next 3Y-0.76%
Revenue Next 5YN/A
EBIT growth 1Y31.56%
EBIT growth 3Y33.02%
EBIT growth 5Y31.85%
EBIT Next Year-11.23%
EBIT Next 3Y-3.62%
EBIT Next 5YN/A
FCF growth 1Y135.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y159.61%
OCF growth 3YN/A
OCF growth 5YN/A